methyl 3-[4-cyclopentyloxy-3-(1-methyl-1H-indazol-5-yl)phenyl]propionate | 590416-81-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子
• 英文名称: methyl 3-[4-cyclopentyloxy-3-(1-methyl-1H-indazol-5-yl)phenyl]propionate
• 英文别名: Methyl 3-[4-cyclopentyloxy-3-(1-methylindazol-5-yl)phenyl]propanoate
• CAS: 590416-81-2
• 化学式: C₂₃H₂₆N₂O₃
• 分子量: 378.471
• InChiKey: SMXLUTGVSNZYHH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  28
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  53.4
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• Substituted phenylalkanoic acid derivatives and use thereof
  申请人：——

  公开号：US20040044258A1

  公开（公告）日：2004-03-04

  A compound represented by the formula (I) or a salt thereof: 1 wherein n represents an integer of 1 to 3, R represents an alkyl group having 3 to 8 carbon atoms, a group represented by the following formula: R 1 (CH 2 ) k — (wherein k represents 0 or an integer of 1 to 3; R 1 represents a saturated cyclic alkyl group having 3 to 7 carbon atoms or a saturated condensed cyclic alkyl group having 6 to 8 carbon atoms, and the group R 1 may be substituted with a lower alkyl group having 1 to 4 carbon atoms) and the like, and Ar represents a condensed bicyclic group such as naphthalen-1-yl group, which has suppressing action on prostaglandin and leukotriene production and is useful for prophylactic and/or therapeutic treatment of various inflammatory diseases and the like caused by these lipid mediators.

  化合物的化学式为（I）或其盐： 其中n表示1到3的整数，R表示具有3到8个碳原子的烷基基团，由以下化学式表示的基团：R1(CH2)k—（其中k表示0或1到3的整数；R1表示具有3到7个碳原子的饱和环烷基基团或具有6到8个碳原子的饱和紧凑环烷基基团，基团R1可以被具有1到4个碳原子的较低烷基基团取代）等，Ar表示如萘-1-基团等的紧凑双环基团，具有对前列腺素和白三烯生成的抑制作用，对由这些脂质介质引起的各种炎症性疾病等的预防和/或治疗治疗有用。
• SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF
  申请人：Asahi Kasei Pharma Corporation

  公开号：EP1477472A1

  公开（公告）日：2004-11-17

  A compound represented by the formula (I) or a salt thereof wherein n represents an integer of 1 to 3, R represents an alkyl group having 3 to 8 carbon atoms, a group represented by the following formula: R1(CH2)k- (wherein k represents 0 or an integer of 1 to 3; R1 represents a saturated cyclic alkyl group having 3 to 7 carbon atoms or a saturated condensed cyclic alkyl group having 6 to 8 carbon atoms, and the group R1 may be substituted with a lower alkyl group having 1 to 4 carbon atoms) and the like, and Ar represents a condensed bicyclic group such as naphthalen-1-yl group, which has suppressing action on prostaglandin and leukotriene production and is useful for prophylactic and/or therapeutic treatment of various inflammatory diseases and the like caused by these lipid mediators.

  由式（I）代表的化合物或其盐 其中 n 代表 1 至 3 的整数，R 代表具有 3 至 8 个碳原子的烷基，由下式代表的基团：R1(CH2)k- （其中 k 代表 0 或 1 至 3 的整数；R1 代表具有 3 至 7 个碳原子的饱和环状烷基或具有 6 至 8 个碳原子的饱和缩合环状烷基，该基团 R1 可被具有 1 至 4 个碳原子的低级烷基取代）等，Ar 代表缩合双环基团，例如萘-1-基团，该基团具有抑制前列腺素和白三烯生成的作用，可用于预防和/或治疗由这些脂质介质引起的各种炎症等。
• US6867320B2
  申请人：——

  公开号：US6867320B2

  公开（公告）日：2005-03-15